These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7016384)

  • 1. Nomograms for drug use in renal disease.
    Chennavasin P; Brater DC
    Clin Pharmacokinet; 1981; 6(3):193-214. PubMed ID: 7016384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Oksenhendler G; Fillastre JP
    Antibiot Chemother (1971); 1978; 25():163-80. PubMed ID: 352252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM; Comte F; Spach MO
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedside determination of aminoglycoside therapy in the patient with renal insufficiency.
    Edwards FH; Davies RS
    Surg Gynecol Obstet; 1983 Jan; 156(1):67-8. PubMed ID: 6847946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobials in renal impairment.
    Lefrock JL; Smith BR
    Am Fam Physician; 1982 Jun; 25(6):201-5. PubMed ID: 7081009
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics--part 4: aminoglycosides.
    Barza M; Scheife RT
    Am J Hosp Pharm; 1977 Jul; 34(7):723-37. PubMed ID: 407790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of astromicin intravenous drip infusion in patients with renal disorders].
    Moriguchi R; Yamagoshi T; Nemoto S; Naide Y; Suzuki K; Inoue A; Kobayashi S
    Jpn J Antibiot; 1986 Jun; 39(6):1480-6. PubMed ID: 3761561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic considerations in the use of antibiotics in renal insufficiency.
    Whelton A
    Obstet Gynecol; 1980 May; 55(5 Suppl):128S-138S. PubMed ID: 6990329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A calculator program for adjusting aminoglycoside regimens that accounts for tissue accumulation in children and adolescents.
    Loertscher MV
    Drug Intell Clin Pharm; 1982; 16(7-8):563-8. PubMed ID: 7105975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.
    Giuliano RA; Verpooten GA; De Broe ME
    Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968
    [No Abstract]   [Full Text] [Related]  

  • 13. Determining aminoglycoside dosage and blood levels using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Feb; 37(2):225-31. PubMed ID: 7361795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
    Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
    Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies of intravenous drip infusion of micronomicin. 1. Pharmacokinetics (Part 2). Intravenous Micronomicin Research Group].
    Watanabe M; Saito I; Mitsuhashi S; Koyama M; Kawaguchi Y
    Jpn J Antibiot; 1985 Apr; 38(4):1086-92. PubMed ID: 4032720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and renal disease on aminoglycoside dosage.
    Hallynck T; Soep HH; Dettli L
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():1-9. PubMed ID: 7263555
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription of aminoglycosides by nomogram.
    Reeves DS
    J Antimicrob Chemother; 1977 Nov; 3(6):533-5. PubMed ID: 599116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.